| 08:00 - 8:45 |
Registration |
| 08:45 - 12:00 |
Plenary Session I |
| Opening ceremony |
| 08:45 - 09:00 |
Prof. Charles Mgone, EDCTP Executive Director
Welcoming address |
| 09:00 - 09:15 |
Dr. Pascoal Mocumbi, EDCTP High Representative |
| 09:15 - 09:30 |
Dr. Diana Dunstan, Chair of EDCTP EEIG-Assembly |
| 09:30 - 10:00 |
Burkina Faso officials
Official opening address |
| 10:00 - 10:30 |
Coffee break |
| 10:30 - 12:00 |
Key-note addresses/Overviews |
| Theme: Recent advances in tuberculosis, malaria and HIV/AIDS Clinical Research |
| Chairs: Chair of EDCTP Partnership Board/Chair of DCCC |
| 10:30 - 11:00 |
Prof. Richard Adegbola, MRC, The Gambia
Update/recent development in TB clinical research in Africa |
| 11:00 - 11:30 |
Prof. Peter Ndumbe, University of Yaounde, Cameroon
Update/recent development in HIV/AIDS clinical research in Africa |
| 11:30 - 12:00 |
Dr Roma Chilengi, AMANET
Update/recent development in malaria clinical research in Africa |
| 12:00 - 13:00 |
Electronic posters sessions |
| 13:00 - 14:00 |
Lunch |
| 14:00 - 17:00 |
Parallel sessions I: Clinical Trials in sub-Saharan Africa
Presentations and facilitated discussion |
Room A: HIV/AIDS
Facilitator/Rapporteur: Lynn Zijenah (DCCC) / Soleymane Mboup (PB) |
| Presentations |
|
| 14:00 - 14:05 |
Introductory remark by the facilitator |
| 14:05 - 14:25 |
Prof. Chifumbe Chintu
CHAPAS Trials: Children with HIV in Africa: Pharmacokinetics and Adherence of Simple Antiretroviral Regimens |
| 14:25 - 14:45 |
Dr Jacques Simpore
Toward the complete eradication of Mother-to-Child transmission of HIV at Saint Camille Medical Centre (SCMC) - Burkina Faso |
| 14:45 - 15:05 |
Prof. Marleen Temmerman
Microbicides trials update |
| 15:05 - 15:25 |
Dr Cheswa Vwalika
A phase 2 HIV preventive vaccine trial in Lusaka - Zambia |
| 15:25 - 15:55 |
Tea break |
| 15:55 - 16:15 |
Dr Joseph Vyankandondera
Phase III Microbicide Trial Preparations in Kigali, Rwanda |
| 16:15 - 16:35 |
Dr Kayitesi Kayitenjore
V001: Phase 1 HIV-1 preventive Vaccine Trial |
| 16:35 - 17:00 |
General discussion |
Room B: Malaria
Facilitator/Rapporteur: Christine Manyando (DCCC) / Peter Kremsner (PB) |
| 14:00 - 14:05 |
Introductory remark by the facilitator |
| 14:05 - 14:25 |
Prof. Umberto d'Alessandro
Evaluation of 4 artemisinin-based combinations for treating uncomplicated malaria in African children |
| 14:25 - 14:45 |
Dr Adoke Yeka
Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment of uncomplicated falciparum malaria, a randomized clinical trial at a high transmission site in Uganda |
| 14:45 - 15:05 |
Dr Mahamadou A Thera
Randomized controlled trial of the Safety and Immunogenicity of recombinant PfAMA1-FVO[25-545] in healthy adult in Bandiagara - Mali |
| 15:05 - 15:25 |
Dr. Theonest Mutabingwa
Malaria in pregnancy |
| 15:25 - 15:55 |
Tea break |
| 15:55 - 16:15 |
Dr. Sodiomon Sirima
MSP3 vaccine in Burkina Faso |
| 16:15 - 16:35 |
Ms Janha Ramatouli
Effects of genetic variation in CYP2C19 gene on pharmacokinetics of chlorcycloguanil |
| 16:35 - 17:00 |
General discussion |
Room C: Tuberculosis
Facilitator/Rapporteur: Joseph Odhiambo (PB) / Thomas Nyirenda (EDCTP SEC) |
| 14:00 - 14:05 |
Introductory remark by the facilitator |
| 14:05 - 14:25 |
Dr Helen McIlleron
Determining the optimal doses of antiretroviral and anti-tuberculosis medications when used in combination for the treatment of HIV/TB in co infected patients |
| 14:25 - 14:45 |
Prof. Andrew Nunn
Rapid Evaluation of Moxifloxacin in the treatment of sputum smear positive tuberculosis: REMoxTB |
| 14:45 - 15:05 |
Dr Idefayo Adetifa
Two Interferon Gamma Release Assays and Tuberculin Skin Test in the diagnosis of Mycobacterium tuberculosis infection and disease in The Gambia |
| 15:05 - 15:25 |
Dr Pere-Joan Cardona
RUTI: a new therapeutic vaccine to shorten the latent tuberculosis infection treatment |
| 15:25 - 15:55 |
Tea break |
| 15:55 - 16:15 |
Dr Aderemi Kehinde
Evaluation of diagnostic tools used for TB diagnosis in Ibadan, Nigeria |
| 16:15 - 16:35 |
Dr Leonie Coetzee
Recruiting Volunteers to participate in a community wide preventive therapy intervention - South Africa |
| 16:35 - 17:00 |
General discussion |